Cheratta A, Thayyullathil F, Pallichankandy S, Subburayan K, Alakkal A, Galadari S
Cell Death Dis. 2021; 12(1):47.
PMID: 33414404
PMC: 7790818.
DOI: 10.1038/s41419-020-03292-1.
Ungefroren H, Wellner U, Keck T, Lehnert H, Marquardt J
Cancers (Basel). 2020; 12(11).
PMID: 33266416
PMC: 7700615.
DOI: 10.3390/cancers12113475.
Gong H, Cheng W, Wang Y
Exp Ther Med. 2019; 17(1):41-50.
PMID: 30651763
PMC: 6307519.
DOI: 10.3892/etm.2018.6901.
Ioannou M, Kouvaras E, Papamichali R, Samara M, Chiotoglou I, Koukoulis G
J Mol Histol. 2018; 49(3):235-244.
PMID: 29468299
DOI: 10.1007/s10735-018-9763-6.
Li Y, Wang L, Zhang H, Wang Y, Liu S, Zhou W
J Cell Mol Med. 2017; 22(1):439-451.
PMID: 29148232
PMC: 5742719.
DOI: 10.1111/jcmm.13334.
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X, Shanmugam C, Paluri R, Jhala N, Behring M, Katkoori V
Oncotarget. 2017; 8(12):20198-20212.
PMID: 28423626
PMC: 5386755.
DOI: 10.18632/oncotarget.15560.
Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer.
Zhang G, Zhou H, Xiao H, Li Y, Zhou T
Cancer Cell Int. 2013; 13(1):104.
PMID: 24152489
PMC: 3832249.
DOI: 10.1186/1475-2867-13-104.
Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz A, Sosa-Garrocho M, Vazquez-Victorio G, Ortiz-Garcia L, Dominguez-Huttinger E, Macias-Silva M
J Biol Chem. 2012; 287(32):26764-76.
PMID: 22674574
PMC: 3411014.
DOI: 10.1074/jbc.M112.386599.
Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε.
Liffers S, Maghnouj A, Munding J, Jackstadt R, Herbrand U, Schulenborg T
BMC Cancer. 2011; 11:137.
PMID: 21492476
PMC: 3095566.
DOI: 10.1186/1471-2407-11-137.
Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.
Rachakonda G, Sekhar K, Jowhar D, SAMSON P, Wikswo J, Beauchamp R
Oncogene. 2010; 29(25):3703-14.
PMID: 20440267
PMC: 2892014.
DOI: 10.1038/onc.2010.118.
Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.
Watanabe T, Miura T, Degawa Y, Fujita Y, Inoue M, Kawaguchi M
Cancer Cell Int. 2010; 10:2.
PMID: 20142997
PMC: 2817686.
DOI: 10.1186/1475-2867-10-2.
Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology.
Smith J, Deane N, Dhawan P, Beauchamp R
Surgery. 2008; 144(3):353-66.
PMID: 18707034
PMC: 2594010.
DOI: 10.1016/j.surg.2008.05.007.
Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5).
Zboralski D, Bockmann M, Zapatka M, Hoppe S, Schoneck A, Hahn S
BMC Cancer. 2008; 8:215.
PMID: 18664273
PMC: 2525660.
DOI: 10.1186/1471-2407-8-215.
High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition.
Klein-Scory S, Zapatka M, Eilert-Micus C, Hoppe S, Schwarz E, Schmiegel W
BMC Cancer. 2007; 7:209.
PMID: 17997817
PMC: 2186346.
DOI: 10.1186/1471-2407-7-209.
Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1.
Lovvorn 3rd H, Boyle S, Shi G, Shyr Y, Wills M, Perantoni A
J Pediatr Surg. 2007; 42(3):474-81.
PMID: 17336183
PMC: 3028602.
DOI: 10.1016/j.jpedsurg.2006.10.054.
Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou S, Singh A, Moorthy K, Datta P, Washington M, Beauchamp R
Cancer Res. 2007; 67(4):1571-9.
PMID: 17308096
PMC: 6574217.
DOI: 10.1158/0008-5472.CAN-06-1680.
Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation.
Onwuegbusi B, Aitchison A, Chin S, Kranjac T, Mills I, Huang Y
Gut. 2005; 55(6):764-74.
PMID: 16368780
PMC: 1856235.
DOI: 10.1136/gut.2005.076430.
Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V, Tang Y, Li C, Jogunoori W, Deng C, Rashid A
Oncogene. 2005; 25(13):1871-86.
PMID: 16288220
PMC: 3821559.
DOI: 10.1038/sj.onc.1209211.
Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
Sanders D
J Clin Pathol. 2005; 58(6):568-72.
PMID: 15917403
PMC: 1770702.
DOI: 10.1136/jcp.2004.021840.
Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis.
Nosho K, Yamamoto H, Adachi Y, Endo T, Hinoda Y, Imai K
Br J Cancer. 2005; 92(7):1193-200.
PMID: 15785755
PMC: 2361982.
DOI: 10.1038/sj.bjc.6602442.